InvestorsHub Logo
Followers 159
Posts 24052
Boards Moderated 0
Alias Born 11/01/2012

Re: None

Tuesday, 05/10/2022 10:20:24 AM

Tuesday, May 10, 2022 10:20:24 AM

Post# of 33
Therapeutics (LOGC) Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Logicbio Therapeutics yesterday and set a price target of $6.00. The company's shares closed last Monday at $0.67, close to its 52-week low of $0.39. According to TipRanks.